To prevent potentially fatal pulmonary emboli, inferior vena cava filters (IVCFs) are implanted in patients with venous
thromboembolism and contraindications to anticoagulation. A systematic review and meta-analysis of 6 randomized clinical trials of IVCFs found slightly decreased rates of pulmonary embolism, increased rates of deep vein thrombosis, and no changes in mortality.
